News for hackers. Stuff that matters.

A comment on GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact. Parent comment

Re:GlaxoSmithKline makes $300M investment in 23andMe, forms ... by koolba on Wednesday July 25, 2018 @02:17PM (#17611481)
Preventative targeted therapies lead to over testing. Even worse there is the perverse incentive of having a for profit company marketing the intersection of their products with person's potential future ailments.

Having the same information available to your doctor (or an AI, ha!) that could parse it objectively would make more sense than a single pharma company. Does anyone really think that GSK is going to suggest you take Viagra (Pfizer) over Cialis (GSK product)?

[ Parent | on HN ]
Re:GlaxoSmithKline makes $300M investment in 23andMe, forms ... by notabee on Wednesday July 25, 2018 @02:50PM (#17611767)
Let's not forget the massive extortion going on with drug prices as well. Also, there seems to be an issue these days with having enough independent replication of results by people who are not on company payrolls, or with selective publication of only positive results. Handing that data to one company is likely not going to result in reliable science by itself.
[ Parent | on HN ]